Indoxyl Sulfate Might Play a Role in Sarcopenia, While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease: Analysis from the RECOVERY Study

Serum myostatin and indoxyl sulfate (IS) levels increase with kidney function decline and may function as uremic toxins in chronic kidney disease (CKD)-related sarcopenia. Herein, we analyzed the association between serum myostatin and IS levels and sarcopenia in patients with CKD, by performing a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su Mi, Han, Mi Yeun, Kim, Su Hyun, Cha, Ran Hui, Kang, Seock Hui, Kim, Jun Chul, An, Won Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610577/
https://www.ncbi.nlm.nih.gov/pubmed/36287929
http://dx.doi.org/10.3390/toxins14100660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610577/
https://www.ncbi.nlm.nih.gov/pubmed/36287929
http://dx.doi.org/10.3390/toxins14100660

Ejemplares similares